Pluristem Therapeutics Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pluristem Therapeutics Inc. on December 11, 2008, reporting an event that occurred on December 8, 2008. The company is incorporated in Nevada and maintains its principal executive offices in Haifa, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
The primary material change reported is the appointment of Shai Pines as an additional member of the Board of Directors. Mr. Pines is a lawyer admitted in Israel since 1981 and currently heads the Commercial and International Transactions Department at Hamburger Evron & Co. He brings prior experience serving on the Supervisory Boards of Globe Trade Centre SA and GTC International BV, as well as membership on the Board of Governors of the Law Faculty at Tel-Aviv University.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on business strategy, or discussion of risks and contingencies. Regarding compensation, Mr. Pines is entitled to participate in the Company's standard director compensation arrangements as described in the 2008 Form 10-K. He is not currently assigned to any specific Board committee.
Key Facts for Investor Verification
- Shai Pines was appointed to the Board of Directors on December 8, 2008.
- Mr. Pines is not currently a member of any Board committee.
- Director compensation is governed by the provisions outlined in the Company's 2008 Annual Report on Form 10-K.
- No financial data or operational metrics are disclosed in this specific filing.